Equities

cbdMD Inc

cbdMD Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.862
  • Today's Change-0.018 / -2.05%
  • Shares traded458.50k
  • 1 Year change-55.34%
  • Beta2.0727
Data delayed at least 15 minutes, as of May 04 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Events & Activity

  • YCBD:ASQ price rises above 200-day moving average to 0.9231 at 14:55 BST
  • YCBD:ASQ price falls below 200-day moving average to 0.9101 at 10:30 BST
  • YCBD:ASQ price falls below 50-day moving average to 0.8322 at 10:58 BST
  • YCBD:ASQ price moved over -9.09% to 1.00
  • YCBD:ASQ price falls below 200-day moving average to 0.9218 at 10:37 BST
  • YCBD:ASQ trading volume exceeds daily average by +49.27%
  • YCBD:ASQ price rises above 15-day moving average to 0.9499 at 10:35 BST
  • YCBD:ASQ price falls below 15-day moving average to 0.95 at 10:37 BST

Key statistics

On Saturday, cbdMD Inc (YCBD:ASQ) closed at 0.862, 53.93% above the 52 week low of 0.56 set on Oct 31, 2023.
52-week range
Today
0.56Oct 31 20232.35May 12 2023
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open0.90
High0.93
Low0.826
Bid0.86
Offer0.9135
Previous close0.88
Average volume410.15k
Shares outstanding3.05m
Free float2.40m
P/E (TTM)--
Market cap2.62m USD
EPS (TTM)-20.34
USD
Data delayed at least 15 minutes, as of May 04 2024.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.